Survival analyses in lung cancer

Por Chansky, Kari, Subotic, Dragan, Foster, Nathan R., Blum, Torsten
Publicado no J Thorac Dis (2016)

Patients’ rationale for declining participation in a cancer-associated weight loss study

Por Wanger, Tammy, Foster, Nathan R., Nguyen, Phuong L., Jatoi, Aminah
Publicado em 2014

Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy

Por Park, Jae Myung, Huang, Shengbing, Wu, Tsung-Teh, Foster, Nathan R., Sinicrope, Frank A.
Publicado em 2013

Obesity Is an Independent Prognostic Variable in Colon Cancer Survivors

Por Sinicrope, Frank A., Foster, Nathan R., Sargent, Daniel J., O’Connell, Michael J., Rankin, Cathryn
Publicado em 2010

Comparison of Error Rates in Single-Arm Versus Randomized Phase II Cancer Clinical Trials

Por Tang, Hui, Foster, Nathan R., Grothey, Axel, Ansell, Stephen M., Goldberg, Richard M., Sargent, Daniel J.
Publicado em 2010

Pemetrexed, Carboplatin, and Concomitant Radiation followed by Surgery for Locally Advanced Esophageal Cancer: Results of a Planned Interim Toxicity Analysis of North Central Cance...

Por Katipamula, Rajini, Jatoi, Aminah, Foster, Nathan R., Nichols, Francis, Rubin, Joseph, Callister, Matthew, Gunderson, Leonard, Alberts, Steven
Publicado em 2008

Phase II Trial of Gemcitabine and Tanespimycin (17AAG) in Metastatic Pancreatic Cancer: A Mayo Clinic Phase II Consortium Study

Por Pedersen, Katrina S., Kim, George P., Foster, Nathan R., Wang-Gillam, Andrea, Erlichman, Charles, McWilliams, Robert R.
Publicado no Invest New Drugs (2015)

A low intraepithelial effector (CD3+):regulatory (FoxP3+) T-cell ratio predicts adverse outcome of human colon carcinoma

Por Sinicrope, Frank A, Rego, Rafaela L, Ansell, Stephen M, Knutson, Keith L, Foster, Nathan R, Sargent, Daniel J
Publicado em 2009

Prognostic Impact of FoxP3+ Regulatory T Cells in Relation to CD8+ T Lymphocyte Density in Human Colon Carcinomas

Por Yoon, Harry H., Orrock, Jared M., Foster, Nathan R., Sargent, Daniel J., Smyrk, Thomas C., Sinicrope, Frank A.
Publicado em 2012

Association of Beclin 1 expression with response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal carcinoma

Por Zaanan, Aziz, Park, Jae Myung, Tougeron, David, Huang, Shengbing, Wu, Tsung-Teh, Foster, Nathan R., Sinicrope, Frank A.
Publicado no Int J Cancer (2015)

Hydronephrosis in patients with cervical cancer: an assessment of morbidity and survival

Por Patel, Krishna, Foster, Nathan R., Kumar, Amanika, Grudem, Megan, Longenbach, Sherri, Bakkum-Gamez, Jamie, Haddock, Michael, Dowdy, Sean, Jatoi, Aminah
Publicado no Support Care Cancer (2014)

Prognostic Impact of Bim, Puma, and Noxa Expression in Human Colon Carcinomas

Por Sinicrope, Frank A., Rego, Rafaela L., Okumura, Kenji, Foster, Nathan R., O’Connell, Michael J., Sargent, Daniel J., Windschitl, Harold E.
Publicado em 2008

Proapoptotic Bad and Bid Protein Expression Predict Survival in Stages II and III Colon Cancers

Por Sinicrope, Frank A., Rego, Rafaela L., Foster, Nathan R., Thibodeau, Stephen N., Alberts, Steven R., Windschitl, Harold E., Sargent, Daniel J.
Publicado em 2008

Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival

Por Jatoi, Aminah, Foster, Nathan R., Kalli, Kimberly R., Vierkant, Robert A., Zhang, Zhiying, Larson, Melissa C., Fridley, Brooke, Goode, Ellen L.
Publicado no BMC Cancer (2015)

Oral Cancer Chemotherapy Adherence and Adherence Assessment Tools: A Report from North Central Cancer Group Trial N0747 and a Systematic Review of the Literature

Por Patel, Krishna, Foster, Nathan R., Farrell, Ann, Le-Lindqwister, Nguyet Anh, Mathew, Josy, Costello, Brian, Reynolds, John, Meyers, Jeffrey P., Jatoi, Aminah
Publicado em 2013

Prognostic Significance of Defective Mismatch Repair and BRAF-V600E in Patients with Colon Cancer

Por French, Amy J., Sargent, Daniel J., Burgart, Lawrence J., Foster, Nathan R., Kabat, Brian F., Goldberg, Richard, Shepherd, Lois, Windschitl, Harold E., Thibodeau, Stephen N.
Publicado em 2008

Phase I Trial of a Pathotropic Retroviral Vector Expressing a Cytocidal Cyclin G1 Construct (Rexin-G) in Patients With Advanced Pancreatic Cancer

Por Galanis, Evanthia, Carlson, Stephanie K, Foster, Nathan R, Lowe, Val, Quevedo, Fernando, McWilliams, Robert R, Grothey, Axel, Jatoi, Aminah, Alberts, Steven R, Rubin, Joseph
Publicado em 2008

A Mixed Methods Feasibility Trial of PKCι Inhibition with Auranofin in Asymptomatic Patients with Ovarian Cancer

Por Jatoi, Aminah, Breitkopf, Carmen Radecki, Foster, Nathan R., Block, Matthew S., Grudem, Megan, Hendrickson, Andrea Wahner, Carlson, Rachel E., Barrette, Brigitte, Karlin, Nina, Fields, Alan P.
Publicado no Oncology (2014)

Association of Obesity With DNA Mismatch Repair Status and Clinical Outcome in Patients With Stage II or III Colon Carcinoma Participating in NCCTG and NSABP Adjuvant Chemotherapy...

Por Sinicrope, Frank A., Foster, Nathan R., Yoon, Harry H., Smyrk, Thomas C., Kim, George P., Allegra, Carmen J., Yothers, Greg, Nikcevich, Daniel A., Sargent, Daniel J.
Publicado em 2012

DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy

Por Sinicrope, Frank A., Foster, Nathan R., Thibodeau, Stephen N., Marsoni, Silvia, Monges, Genevieve, Labianca, Roberto, Yothers, Greg, Allegra, Carmen, Moore, Malcolm J., Gallinger, Steven, Sargent, Daniel J.
Publicado em 2011